SAN FRANCISCO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation therapies to treat cancer and immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results